semaglutide heart health
Experts Warn: GLP-1 / Weight-Loss Drugs Cut Heart Risk
Yes, GLP-1 receptor agonists such as semaglutide and tirzepatide lower the risk of heart attack and stroke for older adults with type 2 diabetes. Clinical trials published between 2024 and 2025 show double-digit reductions in cardiovascular events while also delivering meaningful weight loss. Medical Disclaimer: This article is for informational